Ireland has a unique heritage in the life sciences industry. It is Europe's most established location for pharmaceutical companies with one in 10 people in the country working in the industry. After Minneapolis, Ireland is the second leading exporter of medical devices in the world.

More recently this expertise and know how has transitioned to a number of start up indigenous life science companies. These companies have been formed by highly skilled, experienced professionals who have identified unmet medical needs for which they are developing differentiated value added products.

Fountain was established to capitalise on a unique investment opportunity in Ireland where this broad portfolio of emerging life science companies lack access to dedicated life science venture capital and expertise to further their successful growth and commercialization.

Fountain maintains an office in New York with the view to providing our investee companies a gateway to the largest life science market in the world and to accelerate portfolio company development and ultimate exit.